REPORT ID 6992

Asia-Pacific Antihypertensive Drugs Market Report 2017

Publish Date
1-Nov-17
Pages
119
Format
Electronic (PDF)

In this report, the Asia-Pacific Antihypertensive Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Antihypertensive Drugs for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Antihypertensive Drugs market competition by top manufacturers/players, with Antihypertensive Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Novartis
    Pfizer
    Johnson & Johnson
    Sanofi
    Lupin
    Ranbaxy Laboratories
    Merck
    Astra Zeneca
    Daiichi Sankyo
    Takeda
    Actelion
    United Therapeutics

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
    ARB
    CCB
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Antihypertensive Drugs for each application, includin
    Hypertension
    PAH
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Antihypertensive Drugs Market Report 2017
1 Antihypertensive Drugs Overview
    1.1 Product Overview and Scope of Antihypertensive Drugs
    1.2 Classification of Antihypertensive Drugs by Product Category
        1.2.1 Asia-Pacific Antihypertensive Drugs Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Antihypertensive Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 ARB
        1.2.4 CCB
        1.2.5 Other
    1.3 Asia-Pacific Antihypertensive Drugs Market by Application/End Users
        1.3.1 Asia-Pacific Antihypertensive Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Hypertension
        1.3.3 PAH
        1.3.4 Other
    1.4 Asia-Pacific Antihypertensive Drugs Market by Region
        1.4.1 Asia-Pacific Antihypertensive Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Antihypertensive Drugs (2012-2022)
        1.5.1 Asia-Pacific Antihypertensive Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Antihypertensive Drugs Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Antihypertensive Drugs Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Antihypertensive Drugs Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Antihypertensive Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Antihypertensive Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Antihypertensive Drugs (Volume and Value) by Type
        2.2.1 Asia-Pacific Antihypertensive Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Antihypertensive Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Antihypertensive Drugs (Volume) by Application
    2.4 Asia-Pacific Antihypertensive Drugs (Volume and Value) by Region
        2.4.1 Asia-Pacific Antihypertensive Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Antihypertensive Drugs Revenue and Market Share by Region (2012-2017)

3 China Antihypertensive Drugs (Volume, Value and Sales Price)
    3.1 China Antihypertensive Drugs Sales and Value (2012-2017)
        3.1.1 China Antihypertensive Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Antihypertensive Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 China Antihypertensive Drugs Sales Price Trend (2012-2017)
    3.2 China Antihypertensive Drugs Sales Volume and Market Share by Type
    3.3 China Antihypertensive Drugs Sales Volume and Market Share by Application

4 Japan Antihypertensive Drugs (Volume, Value and Sales Price)
    4.1 Japan Antihypertensive Drugs Sales and Value (2012-2017)
        4.1.1 Japan Antihypertensive Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Antihypertensive Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Antihypertensive Drugs Sales Price Trend (2012-2017)
    4.2 Japan Antihypertensive Drugs Sales Volume and Market Share by Type
    4.3 Japan Antihypertensive Drugs Sales Volume and Market Share by Application

5 South Korea Antihypertensive Drugs (Volume, Value and Sales Price)
    5.1 South Korea Antihypertensive Drugs Sales and Value (2012-2017)
        5.1.1 South Korea Antihypertensive Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Antihypertensive Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Antihypertensive Drugs Sales Price Trend (2012-2017)
    5.2 South Korea Antihypertensive Drugs Sales Volume and Market Share by Type
    5.3 South Korea Antihypertensive Drugs Sales Volume and Market Share by Application

6 Taiwan Antihypertensive Drugs (Volume, Value and Sales Price)
    6.1 Taiwan Antihypertensive Drugs Sales and Value (2012-2017)
        6.1.1 Taiwan Antihypertensive Drugs Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Antihypertensive Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Antihypertensive Drugs Sales Price Trend (2012-2017)
    6.2 Taiwan Antihypertensive Drugs Sales Volume and Market Share by Type
    6.3 Taiwan Antihypertensive Drugs Sales Volume and Market Share by Application

7 India Antihypertensive Drugs (Volume, Value and Sales Price)
    7.1 India Antihypertensive Drugs Sales and Value (2012-2017)
        7.1.1 India Antihypertensive Drugs Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Antihypertensive Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 India Antihypertensive Drugs Sales Price Trend (2012-2017)
    7.2 India Antihypertensive Drugs Sales Volume and Market Share by Type
    7.3 India Antihypertensive Drugs Sales Volume and Market Share by Application

8 Southeast Asia Antihypertensive Drugs (Volume, Value and Sales Price)
    8.1 Southeast Asia Antihypertensive Drugs Sales and Value (2012-2017)
        8.1.1 Southeast Asia Antihypertensive Drugs Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Antihypertensive Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Antihypertensive Drugs Sales Price Trend (2012-2017)
    8.2 Southeast Asia Antihypertensive Drugs Sales Volume and Market Share by Type
    8.3 Southeast Asia Antihypertensive Drugs Sales Volume and Market Share by Application

9 Australia Antihypertensive Drugs (Volume, Value and Sales Price)
    9.1 Australia Antihypertensive Drugs Sales and Value (2012-2017)
        9.1.1 Australia Antihypertensive Drugs Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Antihypertensive Drugs Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Antihypertensive Drugs Sales Price Trend (2012-2017)
    9.2 Australia Antihypertensive Drugs Sales Volume and Market Share by Type
    9.3 Australia Antihypertensive Drugs Sales Volume and Market Share by Application

10 Asia-Pacific Antihypertensive Drugs Players/Suppliers Profiles and Sales Data
    10.1 Novartis
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Antihypertensive Drugs Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Novartis Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Pfizer
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Antihypertensive Drugs Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Pfizer Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Johnson & Johnson
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Antihypertensive Drugs Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Johnson & Johnson Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Sanofi
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Antihypertensive Drugs Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Sanofi Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Lupin
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Antihypertensive Drugs Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Lupin Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Ranbaxy Laboratories
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Antihypertensive Drugs Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Ranbaxy Laboratories Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Merck
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Antihypertensive Drugs Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Merck Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Astra Zeneca
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Antihypertensive Drugs Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Astra Zeneca Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Daiichi Sankyo
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Antihypertensive Drugs Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Daiichi Sankyo Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Takeda
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Antihypertensive Drugs Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Takeda Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Actelion
    10.12 United Therapeutics

11 Antihypertensive Drugs Manufacturing Cost Analysis
    11.1 Antihypertensive Drugs Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Antihypertensive Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Antihypertensive Drugs Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Antihypertensive Drugs Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Antihypertensive Drugs Market Forecast (2017-2022)
    15.1 Asia-Pacific Antihypertensive Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Antihypertensive Drugs Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Antihypertensive Drugs Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Antihypertensive Drugs Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Antihypertensive Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Antihypertensive Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Antihypertensive Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Antihypertensive Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Antihypertensive Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Antihypertensive Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Antihypertensive Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Antihypertensive Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Antihypertensive Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Antihypertensive Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Antihypertensive Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Antihypertensive Drugs Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Antihypertensive Drugs Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Antihypertensive Drugs Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Antihypertensive Drugs Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer